Companies

Deciphex closes out Series B round with additional €4m raise

Dublin-based Seroba Life Sciences has participated in the additional financing along with existing investors

Donal O’Shea, co-founder and chief executive of Deciphex and Jennifer McMahon, a partner at Seroba Life Sciences

Deciphex, a company that develops software to accelerate the delivery of pathology services, has secured an additional €3.9m funding to close its Series B round at €14.4 million.

The financing comes seven months after the firm announced it had raised $11.5 million from backers that includes pharma giant Novartis, contact research organisation Charles River Laboratories, and Act Venture Capital.

Dublin-based Seroba Life Sciences has participated in the additional financing along with existing investors. Jennifer McMahon, ...